A new report from the Nuffield Trust backs concerns among general practice that new tech-based entrants could do more harm than good for the NHS. But that doesn’t mean the search for new solutions ends there
Cutting-edge technologies are increasingly improving pharma’s R&D processes.
The Pharma Challenge saw Amgen, Merck, IQVIA and uMotif collaborate with the NHS on a range of projects to improve care for cancer patients.
The pharma industry is moving on from merely broadcasting on social platforms and starting to listen and engage, appreciating the benefits of mining these rich seams of data.
Alex Butler argues the case that digital advances in healthcare require greater teamwork and understanding of patients to ensure they are successful.
The EU has unveiled plans for greater Health Technology Assessment harmonisation this week – and put the potential benefits for life sciences centre stage.
Nurse plus digital plus patient equals better outcomes.
Should there be a different review of NICE as part of a successor PPRS?